Results 71 to 80 of about 14,017 (290)

Advancing Gel Systems with Natural Extracts: Antioxidant, Antimicrobial Applications, and Sustainable Innovations

open access: yesGels
The integration of natural extracts into gel systems has emerged as a transformative approach to enhance functional properties, including antioxidant, antimicrobial, and therapeutic effects.
Arthitaya Kawee-ai
doaj   +1 more source

Análisis y desarrollo de estrategias de internacionalización de la industria del cannabis medicinal de Colombia

open access: yes, 2020
Este proyecto de investigación se justifica en la posibilidad de ofrecer estrategias para la exportación a otros mercados de productos medicinales a base de cannabis elaborados en Colombia, soportadas en una detallada contextualización de la manera como ...
Pineda Martínez, Karem Bibiana   +2 more
core  

Cannabidiol in Anorexia Nervosa: A Double‐Blind Randomized Placebo Controlled Pilot Study to Test Safety, Pharmacokinetics, and Symptom Change

open access: yesInternational Journal of Eating Disorders, EarlyView.
ABSTRACT Objective Anorexia nervosa (AN) is a severe psychiatric disorder marked by an intense fear of gaining weight and persistent body dissatisfaction, both during periods of underweight and after weight restoration. The endocannabinoid system may offer therapeutic benefits, particularly in reducing anxiety.
Neha Sahota   +8 more
wiley   +1 more source

Patterns of cannabis use, perception of harm, and perceived impact of legislative change in an online sample of young adults from Lebanon: insight on recreational users versus dual motive users

open access: yesHarm Reduction Journal
Background Lebanon remains as one of the major sources of cannabis worldwide. In 2020, its government passed a legislation enabling the cultivation of local medicinal cannabis.
Lilian Ghandour   +3 more
doaj   +1 more source

Cannabis House Colombia: a family business in the colombian pharmaceutical world of cannabis

open access: yes
Cannabis House es una compañía familiar fundada en 2017, gracias a la Ley 1787 de 2016 que autorizó el cultivo y venta de cannabis medicinal en Colombia.
Ospina Becerra, Juan Pablo   +1 more
core   +1 more source

Epilepsy in emerging adulthood: Clinical, psychosocial, and surgical challenges

open access: yesEpilepsia, EarlyView.
Abstract Objective Emerging adulthood (EAs; ages 19–29 years) is a unique developmental stage marked by major psychological, social, and occupational transitions. We sought to characterize the clinical, psychosocial, and surgical features of epilepsy in emerging adulthood, considering both current age and age at epilepsy onset.
Graham A. McLeod   +26 more
wiley   +1 more source

Medicinal cannabis: knowledge, beliefs, and attitudes of Colombian psychiatrists

open access: yesJournal of Cannabis Research, 2021
Background The use of cannabinoids in mental health has gained strength in recent years due to emerging scientific evidence and the lifting of prohibitionist laws that prevailed for years in many countries, including Colombia.
Juan Manuel Orjuela-Rojas   +2 more
doaj   +1 more source

Responsive stimulation of the thalamus for idiopathic generalized epilepsy: Results of the randomized controlled NAUTILUS trial through 18 months

open access: yesEpilepsia, EarlyView.
Abstract Objective This study was undertaken to evaluate the safety and effectiveness of responsive thalamic stimulation as adjunctive therapy for drug‐resistant idiopathic generalized epilepsy (IGE) with generalized tonic–clonic seizures (GTCSs). Methods NAUTILUS is a prospective, multicenter, single‐blind, randomized sham‐controlled pivotal trial ...
Utku Uysal   +47 more
wiley   +1 more source

Medicinal cannabis for pain management would you use it? [PDF]

open access: yes, 2020
Introducción: el dolor crónico es un problema serio de salud pública. Las herramientas terapéuticas disponibles han sido cuestionadas por sus efectos secundarios indeseables.
Trujillo Uribe, Néstor José
core  

Cannabidiol reduces atypical absence seizures and epileptic spasms in a Gabrb3+/D120N mouse model of Lennox–Gastaut syndrome

open access: yesEpilepsia Open, EarlyView.
Abstract Objective Lennox–Gastaut syndrome (LGS) is a drug‐resistant developmental and epileptic encephalopathy (DEE). Preclinical drug development for LGS is constrained by a lack of syndrome‐relevant animal models. We aimed to evaluate a Gabrb3+/D120N knock‐in (KI) mouse model of LGS by quantifying atypical absence seizures and epileptic spasms and ...
Thomas Harman   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy